Global Pharmatech Stock Performance
| GBLP Stock | USD 0.05 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Global Pharmatech are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Global Pharmatech has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable essential indicators, Global Pharmatech is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
Global |
Global Pharmatech Relative Risk vs. Return Landscape
If you would invest 5.00 in Global Pharmatech on September 30, 2025 and sell it today you would earn a total of 0.00 from holding Global Pharmatech or generate 0.0% return on investment over 90 days. Global Pharmatech is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Global, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Global Pharmatech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Global Pharmatech's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Global Pharmatech, and traders can use it to determine the average amount a Global Pharmatech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| GBLP |
Based on monthly moving average Global Pharmatech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Global Pharmatech by adding Global Pharmatech to a well-diversified portfolio.
Global Pharmatech Fundamentals Growth
Global Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Global Pharmatech, and Global Pharmatech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Global Pink Sheet performance.
| Return On Equity | -0.23 | |||
| Return On Asset | -0.1 | |||
| Profit Margin | (0.70) % | |||
| Operating Margin | (0.73) % | |||
| Current Valuation | (1.4 M) | |||
| Price To Earning | (3.23) X | |||
| Price To Book | 0.18 X | |||
| Price To Sales | 0.45 X | |||
| Revenue | 2.82 M | |||
| EBITDA | (1.81 M) | |||
| Cash And Equivalents | 5.44 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 2.62 M | |||
| Debt To Equity | 0.28 % | |||
| Book Value Per Share | 0.34 X | |||
| Cash Flow From Operations | (383.94 K) | |||
| Earnings Per Share | (0.1) X | |||
| Total Asset | 13.33 M | |||
| Retained Earnings | (4 M) | |||
| Current Asset | 8 M | |||
| Current Liabilities | 4 M | |||
About Global Pharmatech Performance
Assessing Global Pharmatech's fundamental ratios provides investors with valuable insights into Global Pharmatech's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Global Pharmatech is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. Global Pharmatech, Inc. was founded in 2001 and is based in Changchun, China. Global Pharmatech operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 217 people.Things to note about Global Pharmatech performance evaluation
Checking the ongoing alerts about Global Pharmatech for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Global Pharmatech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Global Pharmatech generated a negative expected return over the last 90 days | |
| Global Pharmatech has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 2.82 M. Net Loss for the year was (3.3 M) with profit before overhead, payroll, taxes, and interest of 1.32 M. | |
| Global Pharmatech currently holds about 5.44 M in cash with (383.94 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Global Pharmatech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Global Pharmatech's stock is overvalued or undervalued compared to its peers.
- Examining Global Pharmatech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Global Pharmatech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Global Pharmatech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Global Pharmatech's pink sheet. These opinions can provide insight into Global Pharmatech's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Global Pink Sheet Analysis
When running Global Pharmatech's price analysis, check to measure Global Pharmatech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Pharmatech is operating at the current time. Most of Global Pharmatech's value examination focuses on studying past and present price action to predict the probability of Global Pharmatech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Pharmatech's price. Additionally, you may evaluate how the addition of Global Pharmatech to your portfolios can decrease your overall portfolio volatility.